Clark Financial Services Group’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $677K | Sell |
18,805
-460
| -2% | -$16.6K | 0.42% | 30 |
|
|
2025
Q1 | $760K | Buy |
19,265
+5,474
| +40% | +$216K | 0.53% | 26 |
|
|
2024
Q4 | $415K | Sell |
13,791
-81
| -0.6% | -$2.44K | 0.32% | 38 |
|
|
2024
Q3 | $324K | Hold |
13,872
| – | – | 0.3% | 45 |
|
|
2024
Q2 | $246K | Sell |
13,872
-39
| -0.3% | -$692 | 0.26% | 49 |
|
|
2024
Q1 | $211K | Sell |
13,911
-445
| -3% | -$6.75K | 0.25% | 59 |
|
|
2023
Q4 | $246K | Buy |
14,356
+161
| +1% | +$2.76K | 0.32% | 47 |
|
|
2023
Q3 | $119K | Buy |
14,195
+1,860
| +15% | +$15.6K | 0.16% | 57 |
|
|
2023
Q2 | $306K | Sell |
12,335
-4,941
| -29% | -$123K | 0.41% | 40 |
|
|
2023
Q1 | $260K | Sell |
17,276
-550
| -3% | -$8.28K | 0.38% | 43 |
|
|
2022
Q4 | $211K | Buy |
17,826
+622
| +4% | +$7.36K | 0.24% | 54 |
|
|
2022
Q3 | $102K | Buy |
+17,204
| New | +$102K | 0.11% | 57 |
|
|
2022
Q1 | $143K | Sell |
15,018
-44
| -0.3% | -$419 | 0.1% | 60 |
|
|
2021
Q4 | $286K | Sell |
15,062
-113
| -0.7% | -$2.15K | 0.19% | 58 |
|
|
2021
Q3 | $505K | Buy |
15,175
+146
| +1% | +$4.86K | 0.39% | 33 |
|
|
2021
Q2 | $583K | Buy |
15,029
+45
| +0.3% | +$1.75K | 0.46% | 31 |
|
|
2021
Q1 | $722K | Buy |
+14,984
| New | +$722K | 0.61% | 28 |
|
|
2020
Q2 | $75K | Buy |
+17,628
| New | +$75K | 0.12% | 53 |
|